molecular chaperones protein folding proteostasis 
proteins must fold defined three-dimensional structures gain functional activity cellular environment newly synthesized proteins great risk aberrant folding aggregation potentially forming toxic species avoid dangers cells invest complex network molecular chaperones use ingenious mechanisms prevent aggregation promote efficient folding protein molecules highly dynamic constant chaperone surveillance required ensure protein homeostasis proteostasis recent advances suggest age-related decline proteostasis capacity allows manifestation various protein-aggregation diseases including alzheimers disease parkinsons disease interventions numerous pathological states may spring detailed understanding pathways underlying proteome maintenance 
